In recent times, the seafood industry is found to produce large volumes of waste products
comprising shrimp shells, fish bones, fins, skins, intestines, and carcasses, along with the …

Angiotensin converting enzyme inhibitors (ACEi) have consistently demonstrated improved
survival and reduced risk of major cardiovascular events, across the spectrum of …

The current pandemic associated with the novel coronavirus (COVID-19) presents a new
area of research with its own set of challenges. Creating unobtrusive remote monitoring …

Cough is one of the common adverse effects in patients receiving angiotensin-converting
enzyme inhibitors (ACEIs). This review presents the current evidence on incidence and …

Introduction Arterial hypertension represents the leading modifiable risk factor for all-cause
death and early development of cardiovascular disease in women. Current clinical …

Long-term elevated blood pressure will increase the cardiac load and lead to myocardial
fibrosis (MF). A variety of pathological mechanisms and signal transduction pathways are …

Despite many publications related to the identification of new angiotensin-I-converting
enzyme (ACE) inhibitors, especially peptides from natural products, the actual reason/s for …

Asthma is a chronic heterogeneous airway disease. Common comorbid conditions are often
disproportionately present in severe asthma. Optimal care of patients with asthma requires …

Abstract 3D-QSAR, molecular docking and molecular dynamics (MD) simulations were
performed to investigate the mechanism of ACE-inhibitory (ACEi) peptides with tryptophan C …

COVID-19 represents the biggest health challenge. Although the mortality rate of COVID-19
is low, the high numbers of infected people and those with post-COVID-19 symptoms …